Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
This application claims priority to U.S. provisional applications 60/623,252 filed on Oct. 29, 2004 and 60/679,813 filed on May 11, 2005 both of which are hereby incorporated by reference as if written herein in their entirety.
